The Global Proteomics Market Research Report added by Emergen Research to its expanding repository is an all-inclusive document containing insightful data about the Proteomics market and its key elements. The report is formulated through extensive primary and secondary research and is curated with an intent to offer the readers and businesses a competitive edge over other players in the industry. The report sheds light on the minute details of the Proteomics industry pertaining to growth factors, opportunities and lucrative business prospects, regions showing promising growth, and forecast estimation till 2033. The report assesses the historical data and current scenario to offer accurate estimations of the Proteomics market in the coming years.
In today's competitive marketplace, staying ahead of the curve is essential for businesses of all sizes. Understanding consumer behaviour, market trends, and emerging opportunities is crucial for making informed decisions and developing effective strategies. Emergen Research recognizes this need and has invested significant resources in developing a cutting-edge market research content library.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-free-sample/2045
The proteomics market is expected to grow from an estimated USD 34.1 billion in 2024 to USD 100.8 billion in 2033 at a CAGR of 12.80%.
The rising demand for personalized medicine is driven by advances in genomics, biotechnology, and diagnostics, which enable healthcare providers to tailor treatments based on an individual's genetic makeup, lifestyle, and environmental factors. This shift enhances the effectiveness of treatments and minimizes adverse effects. The patients are allegedly teaching themselves into looking for customized therapies while the health care systems are pursued by precision medicine.
However, the ultimate gains can also be realized in terms of improved patient outcomes. One of the critical market drivers is the rising emphasis on personalized medicines in the management of increasingly complex diseases such as cancer, cardiovascular disorders, and genetic disorders. This trend is fueling the demand for proteomics technologies globally.
In June 2024, Agilent Technologies, Inc. (US) launched two new products, the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell available for the 6545XT AdvanceBio LC/Q-TOF, at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics to advance gas chromatography-mass spectrometry (GC/MS) and LC/Q-TOF technology.
Technological advancements in protein analysis have revolutionized the proteomics market by enhancing the sensitivity, accuracy, and throughput of protein identification and quantification. Key innovations include mass spectrometry (MS), next-generation sequencing (NGS), and advanced chromatography techniques, which allow researchers to analyze complex protein samples with greater precision.
More qualified insights into protein structure, function, and interaction become possible with high-resolution MS with LC-MS. These developments enhance biomarker discoveries, potential drug candidates, and the underlying processes of diseases.
Competitive Landscape:
The latest study provides an insightful analysis of the broad competitive landscape of the global Proteomics market, emphasizing the key market rivals and their company profiles. A wide array of strategic initiatives, such as new business deals, mergers & acquisitions, collaborations, joint ventures, technological upgradation, and recent product launches, undertaken by these companies has been discussed in the report.
Higher Investments in the Innovation of Structure-Based Drug Design
The growing demand for targeted therapies in the healthcare sector drives higher investments in the innovation of structure-based drug design. This process basically focuses on understanding the three-dimensional structures of biological molecules, which then leads to the development of better and much more precise drugs. Personalized medicine has further fueled this growth since the treatment would now be based genetically on each patient rather than using a blanket remedy.
Additionally, advancements in computer processing power on one hand and biotechnology on the other have made structure-based design of drugs more efficient. There is a growing incidence of chronic diseases such as diabetes and cancer; these drive investment in more novel ways of drug designing.
All these factors along with developments in the field will push the market growth for proteomics since proteomics is fundamental in the search for druggable targets and paves the way to validate the success of novel therapies for that target. In June 2024, Danaher Corporation (US) and Mass Analytica (Spain) collaborated to reveal artificial intelligence quantitation (AI quant) software, which offers high-resolution MS/MS analysis with an intelligent fragment selection algorithm.
Market Segmentation:
The report bifurcates the Proteomics market on the basis of different product types, applications, end-user industries, and key regions of the world where the market has already established its presence. The report accurately offers insights into the supply-demand ratio and production and consumption volume of each segment.
The prominent companies in the proteomics market are Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), and Waters Corporation (US). These businesses are making substantial investments in proteomics research and development. Promising growth methods like collaborative partnerships, mergers and acquisitions, product launches, and others are increasingly being employed by companies dealing in proteomics to propel their growth.
In February 2023, Waters Corporation (US) acquired Wyatt Technology (US), which enhanced the company's separation and detection portfolio and provided customers with an unmatched set of analytical solutions across a wide range of applications.
Some of the key companies in the global Proteomics Market include:
- Thermo Fisher Scientific Inc. (US)
- Agilent Technologies, Inc. (US)
- Merck KGaA (Germany)
- Danaher Corporation (US)
- Waters Corporation (US)
- Bio-Rad Laboratories, Inc. (US)
- Bruker Corporation (US)
- Revvity (US)
- Shimadzu Corporation (Japan)
- Illumina Inc. (US)
- Promega Corporation (US)
- Eurofins (Luxembourg)
- QIAGEN (Netherlands)
- Charles River Laboratories (US)
- Protagene (Germany)
Our goal at Emergen Research is to empower businesses with the knowledge and insights necessary to make informed decisions and thrive in today's dynamic business landscape. Our market research content is designed to equip professionals and organizations with comprehensive analyses, actionable recommendations, and a competitive edge to achieve their growth objectives.
Custom Requirements can be requested for this Report [Customization Available] @ https://www.emergenresearch.com/request-for-customization/2045
Additional information offered by the report:
- Along with a complete overview of the global Proteomics market, the report provides detailed scrutiny of the diverse market trends observed on both regional and global levels.
- The report elaborates on the global Proteomics market size and share governed by the major geographies.
- It performs a precise market growth forecast analysis, cost analysis, and a study of the micro- and macro-economic indicators.
- It further presents a detailed description of the company profiles of the key market contenders.
Key features and benefits of Emergen Research's market research content include:
Key Questions Answered by the Report:
- Which region is expected to dominate the market in the coming years?
- What are the recent technological and product advancements occurring in the market?
- What are the key strategies adopted by the prominent players in the Proteomics market?
- What are the key product types and applications of the Proteomics industry?
- What is the outcome of SWOT analysis and Porter’s Five Forces analysis?
- How is the competitive landscape of the Proteomics market?
- Who are the key players in the industry?
- What is the growth rate of the industry over the coming years?
- What will be the valuation of the Proteomics Market by 2033?
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/proteomics-market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
English